def add_drug_campaign(cb, drug_code, start_days, coverage=1.0, repetitions=3, interval=60):
    # PROPOSE REPLACING THIS FUNCTION WITH VERSION FROM dtk.interventions.malaria_drug_campaigns
    """
    Add a drug campaign defined by the parameters to the config builder.

    :param cb: The :py:class:`DTKConfigBuilder <dtk.utils.core.DTKConfigBuilder>` that will receive the drug intervention.
    :param drug_code: The drug code of the drug regimen
    :param start_days: List of start days where the drug regimen will be distributed
    :param coverage: Demographic coverage of the distribution
    :param repetitions: Number repetitions
    :param interval: Timesteps between the repetitions
    :return: Nothing
    """

    drug_configs = drug_configs_from_code(cb,drug_code)

    for start_day in start_days:
        drug_event = {
            "class": "CampaignEvent",
            "Start_Day": start_day,
            "Event_Coordinator_Config": {
                "class": "MultiInterventionEventCoordinator",
                "Target_Demographic": "Everyone",
                "Demographic_Coverage": coverage,
                "Intervention_Configs": drug_configs,
                "Number_Repetitions": repetitions,
                "Timesteps_Between_Repetitions": interval
                }, 
            "Nodeset_Config": {
                "class": "NodeSetAll"
                }
            }

        cb.add_event(drug_event)
            
def drug_configs_from_code(cb,drug_code):
    """
    Add a drug config to the simulation configuration based on its code and add the corresponding AntimalarialDrug intervention to the return dictionary.
    The drug_code needs to be one identified in the ``drug_cfg`` dictionary.

    For example passing the ``MDA_ALP`` drug code, will add the drugs config for Artemether, Lumefantrine, Primaquine to the configuration file
    and will return a dictionary containing a Full Treatment course for those 3 drugs.

    :param cb: The :py:class:`DTKConfigBuilder <dtk.utils.core.DTKConfigBuilder>` that will receive the drug configuration
    :param drug_code: Code of the drug to add
    :return: A dictionary containing the parameters for an intervention using the given drug
    """
    dosing_type = "FullTreatmentCourse"
    drug_array = drug_cfg[drug_code]

    cb.set_param("PKPD_Model", "CONCENTRATION_VERSUS_TIME")

    drug_configs = []
    for drug in drug_array:
        cb.config["parameters"]["Malaria_Drug_Params"][drug] = drug_params[drug]
        drug_intervention = {
            "class": "AntimalarialDrug",
            "Drug_Type": drug,
            "Dosing_Type": dosing_type,
            "Cost_To_Consumer": 1.5
        }
        drug_configs.append(drug_intervention)
    return drug_configs

def set_drug_param(cb, drugname, parameter, value):
    """
    Set a drug parameter in the config builder passed.

    :param cb: :py:class:`DTKConfigBuilder <dtk.utils.core.DTKConfigBuilder>` containing the simulation configuration
    :param drugname: The drug that has a parameter to set
    :param parameter:  The parameter to set
    :param value: The new value to set
    :return:
    """
    cb.config['parameters']['Malaria_Drug_Params'][drugname][parameter] = value
    return {'.'.join([drugname, parameter]): value}

def get_drug_param(cb, drugname, parameter):
    """
    Get a parameter for a given drug

    :param cb: The :py:class:`DTKConfigBuilder <dtk.utils.core.DTKConfigBuilder>` holding the configuration
    :param drugname: The drug that holds the parameter we want to retrieve
    :param parameter: The name of the parameter
    :return: The parameter value or None if not found
    """
    try:
        return cb.config['parameters']['Malaria_Drug_Params'][drugname][parameter]
    except:
        print('Unable to get parameter %s for drug %s' % (parameter, drugname))
        return None

# Definitions of drug blocks
drug_params = {

  # Parameterized according to simple model and 50 kg person
  "Artemether": {
     # Drug PkPd
    "Drug_Cmax": 114,                    # dose/(Vc+Vp)*0.5
    "Drug_Decay_T1": 0.12, 
    "Drug_Decay_T2": 0.12, 
    "Drug_Vd": 1, 
    "Drug_PKPD_C50": 0.6,                # based on 2 nM IC50

    # Treatment regimen
    "Drug_Fulltreatment_Doses": 6, 
    "Drug_Dose_Interval": 0.5, 

    # These are daily parasite killing rates for:
     # These are daily parasite killing rates for:
    "Drug_Gametocyte02_Killrate": 2.5,   # ... gametocyte - early stages
    "Drug_Gametocyte34_Killrate": 1.5,   # ...            - late stages
    "Drug_GametocyteM_Killrate":  0.7,   # ...            - mature
    "Drug_Hepatocyte_Killrate":   0.0,   # ... hepatocytes
    "Max_Drug_IRBC_Kill":         8.9,   # ... asexual parasites
    #"Max_Drug_IRBC_Kill":         2.9,   # ... asexual parasites, drug resistant

    # Adherence rate for subsequent doses
    "Drug_Adherence_Rate" : 1.0,

    # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
    "Bodyweight_Exponent": 1,
    "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 3, "Fraction_Of_Adult_Dose": 0.25},{"Upper_Age_In_Years": 6, "Fraction_Of_Adult_Dose": 0.5},{"Upper_Age_In_Years": 10, "Fraction_Of_Adult_Dose": 0.75}]
  },

  "Lumefantrine": {
     # Drug PkPd
    "Drug_Cmax": 1017,
    "Drug_Decay_T1": 1.3, 
    "Drug_Decay_T2": 2.0, 
    "Drug_Vd": 1.2, 
    "Drug_PKPD_C50": 280, 

    # Treatment regimen
    "Drug_Fulltreatment_Doses": 6, 
    "Drug_Dose_Interval": 0.5, 

    # These are daily parasite killing rates for:
    "Drug_Gametocyte02_Killrate": 2.4,   # ... gametocyte - early stages
    "Drug_Gametocyte34_Killrate": 0.0,   # ...            - late stages
    "Drug_GametocyteM_Killrate":  0.0,   # ...            - mature
    "Drug_Hepatocyte_Killrate":   0.0,   # ... hepatocytes
    "Max_Drug_IRBC_Kill":         4.8,   # ... asexual parasites

    # Adherence rate for subsequent doses
    "Drug_Adherence_Rate" : 1.0,

    # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
    "Bodyweight_Exponent": 0.35,
    "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 3, "Fraction_Of_Adult_Dose": 0.25},{"Upper_Age_In_Years": 6, "Fraction_Of_Adult_Dose": 0.5},{"Upper_Age_In_Years": 10, "Fraction_Of_Adult_Dose": 0.75}]
  },

  "DHA": {
     # Drug PkPd
    "Drug_Cmax": 200, 
    "Drug_Decay_T1": 0.12, 
    "Drug_Decay_T2": 0.12, 
    "Drug_Vd": 1, 
    "Drug_PKPD_C50": 0.6, 

    # Treatment regimen
    "Drug_Fulltreatment_Doses": 3, 
    "Drug_Dose_Interval": 1, 

    # These are daily parasite killing rates for:
    "Drug_Gametocyte02_Killrate": 2.5,   # ... gametocyte - early stages
    "Drug_Gametocyte34_Killrate": 1.5,   # ...            - late stages
    "Drug_GametocyteM_Killrate":  0.7,   # ...            - mature
    "Drug_Hepatocyte_Killrate":   0.0,   # ... hepatocytes
    "Max_Drug_IRBC_Kill":         9.2,   # ... asexual parasites
    #"Max_Drug_IRBC_Kill":         3.2,   # ... asexual parasites, drug resistant

    # Adherence rate for subsequent doses
    "Drug_Adherence_Rate" : 1.0,

    # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
    "Bodyweight_Exponent": 1,
    # current sigma-tau dosing
    #"Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 2, "Fraction_Of_Adult_Dose": 0.17},{"Upper_Age_In_Years": 6, "Fraction_Of_Adult_Dose": 0.33},{"Upper_Age_In_Years": 11, "Fraction_Of_Adult_Dose": 0.67}]
    # dosing recommended by Tarning CPT 2012
    "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 0.83, "Fraction_Of_Adult_Dose": 0.375},{"Upper_Age_In_Years": 2.83, "Fraction_Of_Adult_Dose": 0.5},{"Upper_Age_In_Years": 5.25, "Fraction_Of_Adult_Dose": 0.625},
                                     {"Upper_Age_In_Years": 7.33, "Fraction_Of_Adult_Dose": 0.75}, {"Upper_Age_In_Years": 9.42, "Fraction_Of_Adult_Dose": 0.875}]
  },

  "Piperaquine": {
     # Drug PkPd
    "Drug_Cmax": 30,#10.4, 
    "Drug_Decay_T1": 0.17, 
    "Drug_Decay_T2": 41, 
    "Drug_Vd": 49, 
    "Drug_PKPD_C50": 5, 

    # Treatment regimen
    "Drug_Fulltreatment_Doses": 3, 
    "Drug_Dose_Interval": 1, 

    # These are daily parasite killing rates for:
    "Drug_Gametocyte02_Killrate": 2.3,   # ... gametocyte - early stages
    "Drug_Gametocyte34_Killrate": 0.0,   # ...            - late stages
    "Drug_GametocyteM_Killrate":  0.0,   # ...            - mature
    "Drug_Hepatocyte_Killrate":   0.0,   # ... hepatocytes
    "Max_Drug_IRBC_Kill":         4.6,   # ... asexual parasites

    # Adherence rate for subsequent doses
    "Drug_Adherence_Rate" : 1.0,

    # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
    "Bodyweight_Exponent": 0,
    # current sigma-tau dosing
    #"Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 2, "Fraction_Of_Adult_Dose": 0.17},{"Upper_Age_In_Years": 6, "Fraction_Of_Adult_Dose": 0.33},{"Upper_Age_In_Years": 11, "Fraction_Of_Adult_Dose": 0.67}]
    # dosing recommended by Tarning CPT 2012
    "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 0.83, "Fraction_Of_Adult_Dose": 0.375},{"Upper_Age_In_Years": 2.83, "Fraction_Of_Adult_Dose": 0.5},{"Upper_Age_In_Years": 5.25, "Fraction_Of_Adult_Dose": 0.625},
                                     {"Upper_Age_In_Years": 7.33, "Fraction_Of_Adult_Dose": 0.75}, {"Upper_Age_In_Years": 9.42, "Fraction_Of_Adult_Dose": 0.875}]
  },
  
  "Primaquine" : {
     # Drug PkPd
    "Drug_Cmax": 75, #19.5 for 0.065 mg.kg, 30 for 0.1mg/kg, 75 for 0.25 mg/kg, 120 for 0.4 mg/kg, 225 for 0.75 mg/kg
    "Drug_Decay_T1": 0.36, 
    "Drug_Decay_T2": 0.36, 
    "Drug_Vd": 1, 
    "Drug_PKPD_C50": 15,#183, 

    # Treatment regimen
    "Drug_Fulltreatment_Doses": 1, #cmax and dosing for single 45 mg (adult) dose
    "Drug_Dose_Interval": 1, 

    # These are daily parasite killing rates for:
    "Drug_Gametocyte02_Killrate": 2.0,   # ... gametocyte - early stages
    "Drug_Gametocyte34_Killrate": 5.0,   # ...            - late stages
    "Drug_GametocyteM_Killrate":  50.0,   # ...            - mature
    "Drug_Hepatocyte_Killrate":   0.1,   # ... hepatocytes
    "Max_Drug_IRBC_Kill":         0.0,   # ... asexual parasites

    # Adherence rate for subsequent doses
    "Drug_Adherence_Rate" : 1.0,

    # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
    "Bodyweight_Exponent": 1,
    "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 5, "Fraction_Of_Adult_Dose": 0.17},{"Upper_Age_In_Years": 9, "Fraction_Of_Adult_Dose": 0.33},{"Upper_Age_In_Years": 14, "Fraction_Of_Adult_Dose": 0.67}]
  },

  "Chloroquine" : {
     # Drug PkPd
    "Drug_Cmax": 150,
    "Drug_Decay_T1": 8.9,
    "Drug_Decay_T2": 244,
    "Drug_Vd": 3.9,
    "Drug_PKPD_C50": 150,

    # Treatment regimen
    "Drug_Fulltreatment_Doses": 3,
    "Drug_Dose_Interval": 1,

    # These are daily parasite killing rates for:
    "Drug_Gametocyte02_Killrate": 0.0,   # ... gametocyte - early stages
    "Drug_Gametocyte34_Killrate": 0.0,   # ...            - late stages
    "Drug_GametocyteM_Killrate":  0.0,   # ...            - mature
    "Drug_Hepatocyte_Killrate":   0.0,   # ... hepatocytes
    "Max_Drug_IRBC_Kill":         4.8,   # ... asexual parasites

    # Adherence rate for subsequent doses
    "Drug_Adherence_Rate" : 1.0,

    # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
    "Bodyweight_Exponent": 1,
    "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 5, "Fraction_Of_Adult_Dose": 0.17},{"Upper_Age_In_Years": 9, "Fraction_Of_Adult_Dose": 0.33},{"Upper_Age_In_Years": 14, "Fraction_Of_Adult_Dose": 0.67}]
  },

    "Sulfadoxine": {
        # Drug PkPd
        "Drug_Cmax": .64,  # ... Barnes et al. 2006
        "Drug_Decay_T1": 4,
        "Drug_Decay_T2": 4,
        "Drug_Vd": 1,
        "Drug_PKPD_C50": 62,

        # Treatment regimen
        "Drug_Fulltreatment_Doses": 1,
        "Drug_Dose_Interval": 1,

        # These are daily parasite killing rates for:
        "Drug_Gametocyte02_Killrate": 0.0,  # ... gametocyte - early stages
        "Drug_Gametocyte34_Killrate": 0.0,  # ...            - late stages
        "Drug_GametocyteM_Killrate": 0.0,  # ...            - mature
        "Drug_Hepatocyte_Killrate": 0.0,  # ... hepatocytes
        "Max_Drug_IRBC_Kill": .35,  # ... asexual parasites

        # Adherence rate for subsequent doses
        "Drug_Adherence_Rate": 1.0,

        # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
        "Bodyweight_Exponent": 1,
        "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 1, "Fraction_Of_Adult_Dose": 0.16},
                                         {"Upper_Age_In_Years": 2, "Fraction_Of_Adult_Dose": 0.2},
                                         {"Upper_Age_In_Years": 3, "Fraction_Of_Adult_Dose": 0.25},
                                         {"Upper_Age_In_Years": 4, "Fraction_Of_Adult_Dose": 0.27},
                                         {"Upper_Age_In_Years": 5, "Fraction_Of_Adult_Dose": 0.32}]
    },
    "Pyrimethamine": {
        # Drug PkPd
        "Drug_Cmax": 281,  # ... Barnes et al. 2006
        "Drug_Decay_T1": 3,
        "Drug_Decay_T2": 3,
        "Drug_Vd": 1,
        "Drug_PKPD_C50": 24,  # ... Pertersen Eskild 1987

        # Treatment regimen
        "Drug_Fulltreatment_Doses": 1,
        "Drug_Dose_Interval": 1,

        # These are daily parasite killing rates for:
        "Drug_Gametocyte02_Killrate": 0.0,  # ... gametocyte - early stages
        "Drug_Gametocyte34_Killrate": 0.0,  # ...            - late stages
        "Drug_GametocyteM_Killrate": 0.0,  # ...            - mature
        "Drug_Hepatocyte_Killrate": 0.0,  # ... hepatocytes
        "Max_Drug_IRBC_Kill": .35,  # ... asexual parasites; Sanz et al. 2012 PLoS ONE

        # Adherence rate for subsequent doses
        "Drug_Adherence_Rate": 1.0,

        # Cmax modifications due to age-based dosing and bodyweight-dependence Vd ... Zongo et al. 2015
        "Bodyweight_Exponent": 1,
        "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 1, "Fraction_Of_Adult_Dose": 0.16},
                                         {"Upper_Age_In_Years": 2, "Fraction_Of_Adult_Dose": 0.2},
                                         {"Upper_Age_In_Years": 3, "Fraction_Of_Adult_Dose": 0.25},
                                         {"Upper_Age_In_Years": 4, "Fraction_Of_Adult_Dose": 0.27},
                                         {"Upper_Age_In_Years": 5, "Fraction_Of_Adult_Dose": 0.32}]
    },
    "Amodiaquine": {
        # Drug PkPd
        "Drug_Cmax": 478,  # ... Adjei et al. 2008
        "Drug_Decay_T1": 2.7,
        "Drug_Decay_T2": 7,
        "Drug_Vd": 1,
        "Drug_PKPD_C50": 6.4,

        # Treatment regimen
        "Drug_Fulltreatment_Doses": 3,
        "Drug_Dose_Interval": 1,

        # These are daily parasite killing rates for:
        "Drug_Gametocyte02_Killrate": 0.0,  # ... gametocyte - early stages
        "Drug_Gametocyte34_Killrate": 0.0,  # ...            - late stages
        "Drug_GametocyteM_Killrate": 0.0,  # ...            - mature
        "Drug_Hepatocyte_Killrate": 0.0,  # ... hepatocytes
        "Max_Drug_IRBC_Kill": 0.35,  # ... asexual parasites

        # Adherence rate for subsequent doses
        "Drug_Adherence_Rate": 1.0,

        # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
        "Bodyweight_Exponent": 1,
        "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 1, "Fraction_Of_Adult_Dose": 0.16},
                                         {"Upper_Age_In_Years": 2, "Fraction_Of_Adult_Dose": 0.2},
                                         {"Upper_Age_In_Years": 3, "Fraction_Of_Adult_Dose": 0.25},
                                         {"Upper_Age_In_Years": 4, "Fraction_Of_Adult_Dose": 0.27},
                                         {"Upper_Age_In_Years": 5, "Fraction_Of_Adult_Dose": 0.32}]
    },
    "Abstract": { # abstracted drug
     # Drug PkPd
    "Drug_Cmax": 100, 
    "Drug_Decay_T1": 10, 
    "Drug_Decay_T2": 10, 
    "Drug_Vd": 1, 
    "Drug_PKPD_C50": 10, 

    # Treatment regimen
    "Drug_Fulltreatment_Doses": 3, 
    "Drug_Dose_Interval": 1, 

    # These are daily parasite killing rates for:
    "Drug_Gametocyte02_Killrate": 0.0,   # ... gametocyte - early stages
    "Drug_Gametocyte34_Killrate": 0.0,   # ...            - late stages
    "Drug_GametocyteM_Killrate":  0.0,   # ...            - mature
    "Drug_Hepatocyte_Killrate":   0.0,   # ... hepatocytes
    "Max_Drug_IRBC_Kill":         4.8,   # ... asexual parasites

    # Adherence rate for subsequent doses
    "Drug_Adherence_Rate" : 1.0,

    # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
    "Bodyweight_Exponent": 1,
    "Fractional_Dose_By_Upper_Age": [{"Upper_Age_In_Years": 3, "Fraction_Of_Adult_Dose": 0.25},{"Upper_Age_In_Years": 6, "Fraction_Of_Adult_Dose": 0.5},{"Upper_Age_In_Years": 10, "Fraction_Of_Adult_Dose": 0.75}]
  },


    "Vehicle": { #empty drug
     # Drug PkPd
    "Drug_Cmax": 10,
    "Drug_Decay_T1": 1, 
    "Drug_Decay_T2": 1, 
    "Drug_Vd": 10, 
    "Drug_PKPD_C50": 5, 

    # Treatment regimen
    "Drug_Fulltreatment_Doses": 1, 
    "Drug_Dose_Interval": 1, 

    # These are daily parasite killing rates for:
    "Drug_Gametocyte02_Killrate": 0.0,   # ... gametocyte - early stages
    "Drug_Gametocyte34_Killrate": 0.0,   # ...            - late stages
    "Drug_GametocyteM_Killrate":  0.0,   # ...            - mature
    "Drug_Hepatocyte_Killrate":   0.0,   # ... hepatocytes
    "Max_Drug_IRBC_Kill":         0.0,   # ... asexual parasites

    # Cmax modifications due to age-based dosing and bodyweight-dependence Vd
    "Bodyweight_Exponent": 0,
    "Fractional_Dose_By_Upper_Age": []
  }
}


# Different configurations of regimens and drugs
drug_cfg = {
    "ALP": ["Artemether", "Lumefantrine", "Primaquine"],
    "AL" : ["Artemether", "Lumefantrine"],
    "DP" : ["DHA", "Piperaquine"],
    "DPP" : ["DHA", "Piperaquine", "Primaquine"],
    "PPQ" : ["Piperaquine"],
    "DHA_PQ" : ["DHA", "Primaquine"],
    "DHA" : ["DHA"],
    "PMQ" : ["Primaquine"],
    "DA" : ["DHA", "Abstract"],
    "CQ" : ["Chloroquine"],
    "SP" : ["Sulfadoxine", "Pyrimethamine"],
    "SPP" : ["Sulfadoxine", "Pyrimethamine", 'Primaquine'],
    "SPA" : ["Sulfadoxine", "Pyrimethamine", 'Amodiaquine'],
    "Vehicle" : ["Vehicle"]
}
